Dec 20 (Reuters) - Hemostemix Inc HEM.V :
* HEMOSTEMIX RECEIVES HEALTH CANADA CLEARANCE TO CONTINUE WITH CRITICAL LIMB ISCHEMIA CLINICAL TRIALS
* HEMOSTEMIX INC - RECEIVED NO OBJECTION LETTER FROM HEALTH CANADA FOR CURRENT CLINICAL TRIAL OF ACP-01 FOR PATIENTS WITH CRITICAL LIMB ISCHEMIA
* HEMOSTEMIX INC - EXPECTS CLINICAL TRIALS IN UNITED STATES TO RECEIVE CLEARANCE IN EARLY 2018